epigallocatechin gallate has been researched along with Anterior Choroidal Artery Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JB; Koh, PO; Park, DJ | 1 |
| Aggarwal, R; Chakrabarti, A; Kaur, H; Kumar, B; Medhi, B; Modi, M; Radotra, BD; Sinha, VR | 1 |
2 other study(ies) available for epigallocatechin gallate and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats.
Topics: Animals; Apoptosis; Brain Ischemia; Caspase 3; Catechin; Cerebral Infarction; Disease Models, Animal; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley | 2020 |
A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies.
Topics: Animals; Behavior, Animal; Biological Availability; Blood-Brain Barrier; Catechin; Cerebral Infarction; Disease Models, Animal; Drug Compounding; Drug Liberation; Emulsions; Humans; Lipids; Male; Memory Disorders; Mice; Nanoparticles; Neuroprotective Agents; Treatment Outcome | 2019 |